First Trust Advisors LP Raises Stock Position in Mettler-Toledo International, Inc. $MTD

First Trust Advisors LP grew its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 1.3% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 33,900 shares of the medical instruments supplier’s stock after acquiring an additional 448 shares during the period. First Trust Advisors LP owned about 0.16% of Mettler-Toledo International worth $39,823,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also modified their holdings of the company. Bank of New York Mellon Corp increased its stake in Mettler-Toledo International by 71.3% in the 2nd quarter. Bank of New York Mellon Corp now owns 904,264 shares of the medical instruments supplier’s stock valued at $1,062,257,000 after purchasing an additional 376,419 shares in the last quarter. Norges Bank acquired a new stake in Mettler-Toledo International in the second quarter valued at $360,126,000. Alliancebernstein L.P. increased its position in shares of Mettler-Toledo International by 21.6% in the first quarter. Alliancebernstein L.P. now owns 709,328 shares of the medical instruments supplier’s stock valued at $837,653,000 after buying an additional 126,147 shares in the last quarter. PineStone Asset Management Inc. raised its stake in shares of Mettler-Toledo International by 41.9% during the 2nd quarter. PineStone Asset Management Inc. now owns 334,349 shares of the medical instruments supplier’s stock worth $392,766,000 after buying an additional 98,737 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in shares of Mettler-Toledo International by 42.0% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 305,722 shares of the medical instruments supplier’s stock worth $361,030,000 after buying an additional 90,395 shares during the last quarter. Institutional investors and hedge funds own 95.07% of the company’s stock.

Insider Buying and Selling at Mettler-Toledo International

In other Mettler-Toledo International news, insider Gerry Keller sold 236 shares of the company’s stock in a transaction dated Friday, November 21st. The stock was sold at an average price of $1,418.58, for a total transaction of $334,784.88. Following the completion of the sale, the insider directly owned 159 shares in the company, valued at $225,554.22. This represents a 59.75% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider La Guerroniere Marc De sold 6,055 shares of Mettler-Toledo International stock in a transaction dated Tuesday, November 25th. The shares were sold at an average price of $1,488.18, for a total value of $9,010,929.90. Following the completion of the transaction, the insider directly owned 187 shares in the company, valued at $278,289.66. This represents a 97.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 19,565 shares of company stock worth $28,683,737. 0.77% of the stock is currently owned by company insiders.

Mettler-Toledo International Price Performance

NYSE MTD opened at $1,371.94 on Wednesday. The company has a market cap of $28.03 billion, a P/E ratio of 34.21, a P/E/G ratio of 4.46 and a beta of 1.40. Mettler-Toledo International, Inc. has a 12 month low of $946.69 and a 12 month high of $1,525.17. The company has a 50-day moving average of $1,395.79 and a 200-day moving average of $1,288.40.

Mettler-Toledo International (NYSE:MTD) last released its earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $10.62 by $0.53. Mettler-Toledo International had a net margin of 21.20% and a negative return on equity of 426.96%. The business had revenue of $1.03 billion for the quarter, compared to analysts’ expectations of $997.36 million. During the same period last year, the company earned $10.21 earnings per share. The company’s quarterly revenue was up 7.9% on a year-over-year basis. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS and its FY 2025 guidance at 42.050-42.250 EPS. As a group, equities research analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on the stock. Citigroup raised their target price on shares of Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the company a “buy” rating in a report on Monday, November 10th. JPMorgan Chase & Co. increased their price target on shares of Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the company a “neutral” rating in a research report on Thursday, October 9th. Evercore ISI lifted their price objective on Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 7th. The Goldman Sachs Group assumed coverage on Mettler-Toledo International in a research note on Tuesday. They issued a “neutral” rating and a $1,475.00 target price on the stock. Finally, Wells Fargo & Company raised their price target on Mettler-Toledo International from $1,200.00 to $1,400.00 and gave the stock an “equal weight” rating in a research report on Monday, November 10th. Five analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $1,424.17.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.